Psy122 - Management of Poor Prognosis Multiple Myeloma Patients Under Regular Clinical Conditions in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epstein-Barr Virus Infection Is Associated With Clinical Characteristics and Poor Prognosis of Multiple Myeloma

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Management of Older Patients With Multiple Myeloma

Blood Reviews
OncologyHematology
2011English

High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Impact of Vitamin D Deficiency on the Clinical Presentation and Prognosis of Patients With Newly Diagnosed Multiple Myeloma

American Journal of Hematology
Hematology
2009English

Latest Advances in the Management of Elderly Patients With Multiple Myeloma

International Journal of Hematologic Oncology
OncologyHematologyPharmacology
2013English

Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer
Oncology
2020English

Advances in the Management of Multiple Myeloma

Journal of Community and Supportive Oncology
OncologyHematology
2016English

Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion

Modern Pathology
Forensic MedicinePathology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy